Daniel Sommermeyer

7.2k total citations · 2 hit papers
39 papers, 3.8k citations indexed

About

Daniel Sommermeyer is a scholar working on Oncology, Immunology and Genetics. According to data from OpenAlex, Daniel Sommermeyer has authored 39 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Oncology, 27 papers in Immunology and 7 papers in Genetics. Recurrent topics in Daniel Sommermeyer's work include CAR-T cell therapy research (35 papers), Immune Cell Function and Interaction (16 papers) and Immunotherapy and Immune Responses (15 papers). Daniel Sommermeyer is often cited by papers focused on CAR-T cell therapy research (35 papers), Immune Cell Function and Interaction (16 papers) and Immunotherapy and Immune Responses (15 papers). Daniel Sommermeyer collaborates with scholars based in United States, Germany and Canada. Daniel Sommermeyer's co-authors include Stanley R. Riddell, Michael Hudecek, Paula L. Kosasih, Michael C. Jensen, Christoph Rader, Wolfgang Uckert, Lingfeng Liu, David G. Maloney, Cameron J. Turtle and Tea Gogishvili and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Daniel Sommermeyer

37 papers receiving 3.7k citations

Hit Papers

Chimeric antigen receptor-modified T cells derived from d... 2014 2026 2018 2022 2015 2014 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Chimeric antigen receptor-modified T cells derived from defined CD8+ and CD4+ subsets confer superior antitumor reactivity in vivo
    2015 639 citations Daniel Sommermeyer, Michael Hudecek et al. Leukemia profile →
  2. The Nonsignaling Extracellular Spacer Domain of Chimeric Antigen Receptors Is Decisive for In Vivo Antitumor Activity
    2014 406 citations Michael Hudecek, Daniel Sommermeyer et al. Cancer Immunology Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Sommermeyer United States 25 3.4k 1.5k 1.2k 1.1k 1.1k 39 3.8k
Terence J. Purdon United States 22 2.9k 0.8× 1.1k 0.7× 963 0.8× 1.0k 0.9× 837 0.8× 41 3.1k
Sjoukje J. C. van der Stegen United States 13 4.1k 1.2× 1.5k 1.0× 1.7k 1.4× 1.5k 1.3× 1.3k 1.3× 18 4.7k
Mohamad Hamieh United States 14 3.8k 1.1× 1.5k 1.0× 1.7k 1.4× 1.3k 1.1× 1.2k 1.2× 26 4.6k
Carolina Berger United States 28 3.0k 0.9× 1.5k 1.0× 1.2k 1.0× 782 0.7× 1.1k 1.1× 49 3.9k
Justin Eyquem United States 17 3.6k 1.1× 1.3k 0.9× 2.0k 1.7× 1.2k 1.1× 1.3k 1.2× 33 4.5k
Helen Huls United States 31 2.9k 0.8× 1.3k 0.8× 1.4k 1.1× 852 0.8× 1.3k 1.3× 55 3.7k
Yelei Guo China 29 3.2k 0.9× 1.1k 0.7× 977 0.8× 932 0.8× 853 0.8× 38 3.7k
Eric Yvon United States 28 2.6k 0.8× 1.8k 1.2× 900 0.8× 698 0.6× 867 0.8× 49 3.6k
Zhuyong Mei United States 22 3.8k 1.1× 1.9k 1.2× 1.2k 1.0× 1.0k 0.9× 1.4k 1.3× 35 4.5k
Rachel C. Lynn United States 16 2.4k 0.7× 1.4k 1.0× 938 0.8× 698 0.6× 634 0.6× 30 3.2k

Countries citing papers authored by Daniel Sommermeyer

Since Specialization
Citations

This map shows the geographic impact of Daniel Sommermeyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Sommermeyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Sommermeyer more than expected).

Fields of papers citing papers by Daniel Sommermeyer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Sommermeyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Sommermeyer. The network helps show where Daniel Sommermeyer may publish in the future.

Co-authorship network of co-authors of Daniel Sommermeyer

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Sommermeyer. A scholar is included among the top collaborators of Daniel Sommermeyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Sommermeyer. Daniel Sommermeyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Sommermeyer, Daniel, Tyler Hill, Steven M. Shamah, et al.. (2017). Fully human CD19-specific chimeric antigen receptors for T-cell therapy. Leukemia. 31(10). 2191–2199. 162 indexed citations
3.
Sommermeyer, Daniel, et al.. (2017). Development of T-cell immunotherapy for hematopoietic stem cell transplantation recipients at risk of leukemia relapse. Blood. 131(1). 108–120. 71 indexed citations
4.
Balakrishnan, Ashwini, Tracy Goodpaster, Julie Randolph‐Habecker, et al.. (2016). Analysis of ROR1 Protein Expression in Human Cancer and Normal Tissues. Clinical Cancer Research. 23(12). 3061–3071. 151 indexed citations
5.
Paszkiewicz, Paulina J., Simon P. Fräßle, Shivani Srivastava, et al.. (2016). Targeted antibody-mediated depletion of murine CD19 CAR T cells permanently reverses B cell aplasia. Journal of Clinical Investigation. 126(11). 4262–4272. 222 indexed citations
6.
Busch, Dirk H., Simon P. Fräßle, Daniel Sommermeyer, Veit R. Buchholz, & Stanley R. Riddell. (2016). Role of memory T cell subsets for adoptive immunotherapy. Seminars in Immunology. 28(1). 28–34. 167 indexed citations
7.
Sommermeyer, Daniel, Michael Hudecek, Paula L. Kosasih, et al.. (2015). Chimeric antigen receptor-modified T cells derived from defined CD8+ and CD4+ subsets confer superior antitumor reactivity in vivo. Leukemia. 30(2). 492–500. 639 indexed citations breakdown →
8.
9.
Turtle, Cameron J., Carolina Berger, Daniel Sommermeyer, et al.. (2015). Immunotherapy with CD19-specific chimeric antigen receptor (CAR)-modified T cells of defined subset composition.. Journal of Clinical Oncology. 33(15_suppl). 3006–3006. 13 indexed citations
10.
Berger, Carolina, Daniel Sommermeyer, Michael Hudecek, et al.. (2014). Safety of Targeting ROR1 in Primates with Chimeric Antigen Receptor–Modified T Cells. Cancer Immunology Research. 3(2). 206–216. 139 indexed citations
11.
Hudecek, Michael, Daniel Sommermeyer, Paula L. Kosasih, et al.. (2014). The Nonsignaling Extracellular Spacer Domain of Chimeric Antigen Receptors Is Decisive for In Vivo Antitumor Activity. Cancer Immunology Research. 3(2). 125–135. 406 indexed citations breakdown →
12.
Riddell, Stanley R., Daniel Sommermeyer, Carolina Berger, et al.. (2014). Adoptive Therapy With Chimeric Antigen Receptor–Modified T Cells of Defined Subset Composition. The Cancer Journal. 20(2). 141–144. 86 indexed citations
13.
Hudecek, Michael, Maria Teresa Lupo Stanghellini, Paula L. Kosasih, et al.. (2013). Receptor Affinity and Extracellular Domain Modifications Affect Tumor Recognition by ROR1-Specific Chimeric Antigen Receptor T Cells. Clinical Cancer Research. 19(12). 3153–3164. 424 indexed citations
14.
Sommermeyer, Daniel, et al.. (2012). NY‐ESO‐1 antigen‐reactive T cell receptors exhibit diverse therapeutic capability. International Journal of Cancer. 132(6). 1360–1367. 12 indexed citations
15.
Sommermeyer, Daniel & Wolfgang Uckert. (2010). Minimal Amino Acid Exchange in Human TCR Constant Regions Fosters Improved Function of TCR Gene-Modified T Cells. The Journal of Immunology. 184(11). 6223–6231. 99 indexed citations
16.
Briesemeister, Dana, Daniel Sommermeyer, Christoph Loddenkemper, et al.. (2010). Tumor rejection by local interferon gamma induction in established tumors is associated with blood vessel destruction and necrosis. International Journal of Cancer. 128(2). 371–378. 47 indexed citations
17.
Weigand, Luise, Ingrid Schuster, Matthias Leisegang, et al.. (2009). A Single TCRα-Chain with Dominant Peptide Recognition in the Allorestricted HER2/neu-Specific T Cell Repertoire. The Journal of Immunology. 184(3). 1617–1629. 27 indexed citations
18.
Leisegang, Matthias, Boris Engels, Elisa Kieback, et al.. (2008). Enhanced functionality of T cell receptor-redirected T cells is defined by the transgene cassette. Journal of Molecular Medicine. 86(7). 855–855. 5 indexed citations
19.
Leisegang, Matthias, Boris Engels, Elisa Kieback, et al.. (2008). Enhanced functionality of T cell receptor-redirected T cells is defined by the transgene cassette. Journal of Molecular Medicine. 86(5). 573–583. 99 indexed citations
20.
Sommermeyer, Daniel, et al.. (2007). Dual T Cell Receptor Expressing CD8+ T Cells with Tumor- and Self-Specificity Can Inhibit Tumor Growth without Causing Severe Autoimmunity. The Journal of Immunology. 179(8). 5534–5542. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Terence J. Purdon Breakdown of academic impact, for papers by Sjoukje J. C. van der Stegen Breakdown of academic impact, for papers by Mohamad Hamieh Breakdown of academic impact, for papers by Carolina Berger Breakdown of academic impact, for papers by Justin Eyquem Breakdown of academic impact, for papers by Helen Huls Breakdown of academic impact, for papers by Yelei Guo Breakdown of academic impact, for papers by Eric Yvon Breakdown of academic impact, for papers by Zhuyong Mei Breakdown of academic impact, for papers by Rachel C. Lynn
Rankless by CCL
2026